Clinical Trial Update: Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） [NA]

View source ↗

Summary

A ChinECR study is evaluating immunotherapy combined with chemoradiotherapy as first-line treatment for esophageal squamous cell carcinoma. The trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Immunotherapy plus chemoradiotherapy (unspecified agents)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: ESCC | NA | Status: ACTIVE_NOT_RECRUITING